Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Regenerative medical devices company Tissue Regenix Group said that CEO Steve Couldwell had resigned his position 'with immediate effect' due to a recurrence of illness.
The firm said John Samuel would resume the position of executive chairman until a full time CEO appointment was made while COO Gareth Jones would take up the position of interim- CEO.
Mike Barker would continue to support the executive team as interim finance director.
At 9:45am: (LON:TRX) Tissue Regenix Group PLC share price was 0p at 3.75p